Tiroid hemiagenezili bir hastada Graves hastalığına bağlı hiperkalsemi

Tiroid hemiagenezisi embriyolojik yaşam sırasında bir tiroid lobunun gelişim yetersizliğine bağlı nadir bir anomalidir. Birçok tiroid hastalığı tiroid hemia- genezisine eşlik edebilir. Bu yazıda Graves’ has- talığına bağlı orta düzeyde hiperkalsemisi olan bir tiroid hemiagenezisi olgusu sunuldu. Kırk üç yaşın- da bir kadın bir ay içinde 5 kg’dan fazla kilo kaybı, sıcağa tahammülsüzlük ve aşırı terleme yakınması ile kliniğimize başvurdu. Son ay içinde belirli aralık- larla kusma, susama ve kabızlık semptomları vardı. Muayenesinde dehidrasyon bulguları olmaksızın taşikardisi olduğu saptandı. Nabız dakikada 110 idi. Hafif titremesi ve proksimal kas zayıflığı olan hastada tiroid glandın sağ lobunda hiperplazi ve asimetrik düz guatr saptandı. Tiroid fonksiyon test- leri hipertiroidizm tanısını doğruladı. Hiperkalsemi tirotoksikozlu hastalarda saptanabilmesine karşın, yaptığımız literatür taramasına göre, hastamız tiro- toksikoza bağlı hiperkalsemiye eşlik eden ilk tiroid hemiagenezisi olgusudur

Hypercalcemia due to Graves’ disease in a patient with thyroid hemiagenesis

Thyroid hemiagenesis is a rare anomaly due to failure of development of one thyroid lobe during embryological life. A lot of thyroid disorders may accompany thyroid hemiagenesis. In this report, we present a case of thyroid hemiagenesis, who had moderate hypercalcemia due to Graves’ disease. A 43-year-old woman presented with weight loss of more than 5 kg within one month, heat intolerance, and increased sweating. For the past month, she had been troubled by intermittent symptoms of vomiting, thirst, and constipation. On examination, she had tachycardia with no signs of dehydration. Pulse rate was 110 per minute. She had fine tremor, proximal muscle weakness, and asymmetric smooth goiter and hyperplasia in the right thyroid gland. Thyroid function tests confirmed the diagnosis of hyperthyroidism. Although hypercalcemia may be detected in patients with thyrotoxicosis, to the best of our knowledge, this is the first case report of thyroid hemiagenesis accompanying hypercalcemia due to thyrotoxicosis.

___

  • Shaha AR, Gujarati R. Thyroid hemiagenesis. J Surg Oncol 1997;65:137-40.
  • Sari O, Ciftçi I, Törü M, Erbaş B. Thyroid hemiagenesis. Clin Nucl Med 2000;25:766-8.
  • Karabay N, Comlekci A, Canda MS, Bayraktar F, Degirmenci B. Thyroid hemiagenesis with multinodu- lar goiter: a case report and review of the literature. Endocr J 2003;50:409-13.
  • Ozgen AG, Saygili F, Kabalak T. Thyroid hemiagenesis associated with Graves’ disease and Graves’ ophthal- mopathy: case report. Thyroid 2004;14:75-7.
  • Büyükdereli G, Guney IB, Kibar M, Kinaci C. Thyroid hemiagenesis: a report of three cases and review of the literature. Ann Nucl Med 2005;19:147-50.
  • Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 1976;58:529-34.
  • Burman KD, Monchik JM, Earll JM, Wartofsky L. Ionized and total serum calcium and parathyroid hormone in hyperthyroidism. Ann Intern Med 1976;84:668-71.
  • Baxter JD, Bondy PK. Hypercalcemia of thyrotoxicosis. Ann Intern Med 1966;65:429-42.
  • Shabana W, Delange F, Freson M, Osteaux M, De Schepper J. Prevalence of thyroid hemiagenesis: ultra- sound screening in normal children. Eur J Pediatr 2000;159:456-8.
  • Maiorana R, Carta A, Floriddia G, Leonardi D, Buscema M, Sava L, et al. Thyroid hemiagenesis: prevalence in normal children and effect on thyroid function. J Clin Endocrinol Metab 2003;88:1534-6.
  • Prakash R, Narayanan RV, Chakravarty SK. Differentiation between suppressed thyroid tissue and thyroid hemiagenesis with Tc-99m pertechnetate radi- onuclide angiography. Clin Nucl Med 1990;15:605-9.
  • Pintar JE. Normal development of the hypothalamic- pituitary thyroid axis. In: Braverman LE, Utiger RD, editors. The thyroid. 7th ed. Philadelphia: Lippincott- Raven; 1996. p. 6-18.
  • Rosenberg T, Gilboa Y. Familial thyroid ectopy and hemiagenesis. Arch Dis Child 1980;55:639-41.
  • Bouillon R, Muls E, De Moor P. Influence of thy- roid function on the serum concentration of 1,25- dihydroxyvitamin D3. J Clin Endocrinol Metab 1980; 51:793-7.